Inhibition of angiogenesis by two-chain high molecular weight kininogen (HKa) and kininogen-derived polypeptides

Canadian Journal of Physiology and Pharmacology

Volumn 80, Issue 2, 2002, Pages 85-90

  Zhang, Jing Chuan ^a   Qi, Xiaoping ^a   Juarez, Jose ^a   Plunkett, Marian ^a   Donaté, Fernando ^a   Sakthivel, Ramasamy ^a   Mazar, Andrew P ^a   McCrae, Keith R ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Apoptosis; Endothelial cells; Kininogen; Peptides

Indexed keywords

EPIDERMAL GROWTH FACTOR; HIGH MOLECULAR WEIGHT KININOGEN; POLYPEPTIDE; VASCULOTROPIN; ZINC;

ANGIOGENESIS; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BINDING SITE; CELL PROLIFERATION; CELL STRUCTURE; CHICKEN; CHORIOALLANTOIS; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; EMBRYO; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION;

ANGIOGENESIS INHIBITORS; ANIMALS; APOPTOSIS; CELL DIVISION; CHICK EMBRYO; ENDOTHELIUM, VASCULAR; FIBROBLASTS; HUMANS; KININOGEN, HIGH-MOLECULAR-WEIGHT; PEPTIDE FRAGMENTS; ZINC;

EID: 0036205177     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y02-011     Document Type: Article

References (19)

1. Inhibition of cell adhesion by high molecular weight kininogen
2. The hemostatic system as a regulator of angiogenesis
3. Contact system: A vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive and proinflammatory attributes
4. Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2+3 of the urokinase receptor
5. Urokinase/urokinase receptor and vitronectin/alpha(v)beta(3) integrin induce chemotaxis and cytoskeleton reorganization through different signaling pathways
6. The sequence HGLGHGEQQHGLGHGH in the light chain of high molecular weight kininogen serves as a primary structural feature for zinc-dependent binding to an anionic surface
7. Identification of cytokeratin as a binding protein and presentation receptor for kininogens on endothelial cells
8. Identification of an endothelial cell binding site on kininogen domain D3
9. Isolation and characterization of the kininogen binding protein p33 from endothelial cells
10. Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: Identity with the receptor that binds to the globular "heads" of C1q (gC1q-R)
11. The coagulation-kinin pathway of human plasma
12. Proliferation of a human epidermal tumor cell line stimulated by urokinase
13. Studies on human high molecular weight (HMW) kininogen II: Structural change of HMW kininogen by the action of human plasma kallikrein II
14. Quantitation of angiogenesis and antiangiogenesis in the chick chorioallantoic membrane
15. Urokinase-type plasminogen activator stimulates the Ras/Extracellular signal-regulated kinase (ERK) signaling pathway and MCF-7 cell migration by a mechanism that requires focal adhesion kinase, Src, and Shc. Rapid dissociation of GRB2/Sps-Shc complex is associated with the transient phosphorylation of ERK in urokinase-treated cells
16. High molecular weight kininogen utilizes heparan sulfate proteoglycans for accumulation on endothelial cells
17. Pieces of eight: Bioactive fragments of extracellular matrix proteins as regulators of angiogenesis
18. The urokinase-type plasminogen activator receptor mediates tyrosine phosphorylation of focal adhesion proteins and activation of mitogen-activated protein kinase in cultured endothelial cells
19. Cleaved high molecular weight kininogen promotes endothelial cell apoptosis and inhibits angiogenesis in vivo